A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol
The GIMEMA LAL1509 protocol, designed for adult (≥18-60 years) de novo Ph+ acute lymphoblastic leukemia patients, was based on a dasatinib plus steroids induction - with central nervous system prophylaxis - followed by dasatinib alone in patients in complete molecular response or chemotherapy and/o...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Ferrata Storti Foundation
2021-02-01
|
| Seria: | Haematologica |
| Dostęp online: | https://haematologica.org/article/view/10165 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
